
Loading, please wait...

Loading, please wait...

The Ponseti method has largely replaced extensive surgical release as the first-line treatment for idiopathic clubfoot, but high-quality long-term comparative data are uncommon. This prospective randomized trial compared Ponseti treatment with surgical correction and followed children for approximately 10 years. The study assessed morphology, function, radiographic findings, overall health and gait, providing a longer-term perspective than many short series. The results support Ponseti treatment as the preferred initial strategy and demonstrate that early conservative correction can translate into durable functional outcomes. The study is particularly relevant because it compares treatments over a time horizon long enough to capture late functional differences and the potential consequences of more extensive surgery. Clinically, the success of Ponseti does not depend on casting alone: careful serial manipulation, Achilles tenotomy when indicated and prolonged bracing are integral components. Families need realistic counselling about the importance of follow-up and the possibility of relapse. The broader lesson for HCPs is that successful clubfoot management is a longitudinal care pathway, not a single procedure. When recurrence occurs, early recognition and repeat Ponseti-based treatment can often avoid major reconstructive surgery.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Ponseti method has largely replaced extensive surgical release as the first-line treatment for idiopathic clubfoot, but high-quality long-term comparative data are uncommon. This prospective randomized trial compared Ponseti treatment with surgical correction and followed children for approximately 10 years. The study assessed morphology, function, radiographic findings, overall health and gait, providing a longer-term perspective than many short series. The results support Ponseti treatment as the preferred initial strategy and demonstrate that early conservative correction can translate into durable functional outcomes. The study is particularly relevant because it compares treatments over a time horizon long enough to capture late functional differences and the potential consequences of more extensive surgery. Clinically, the success of Ponseti does not depend on casting alone: careful serial manipulation, Achilles tenotomy when indicated and prolonged bracing are integral components. Families need realistic counselling about the importance of follow-up and the possibility of relapse. The broader lesson for HCPs is that successful clubfoot management is a longitudinal care pathway, not a single procedure. When recurrence occurs, early recognition and repeat Ponseti-based treatment can often avoid major reconstructive surgery.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back